Comparative Assessment of NIMs (LIVERFASt/ELF/FIB-4/LSM) in a prospective cohort with chronic liver diseases (Thailand) easlfibronostg on June 26, 2026 Category: Publications Tag: Hep B, Hep C, Identification, LIVERFASt, MASLD, NAFLD Post navigation Previous: Previous post: Application of LIVERFASt biomarkers to evaluate longitudinal hepatic fibrosis and inflammation after HCV cureNext: Next post: Repeated noninvasive liver biopsy surrogate LIVERFASt correlates with BMI and liver enzyme improvements (regression poster)
